![2024-03-SCOR_URD_2023_header](/sites/default/files/styles/img_search_list_desktop/public/2024-03/2024-03-SCOR_URD_2023_header.jpg?h=82f92a78&itok=vg-oBcmp)
![2024-03-SCOR_URD_2023_header](/sites/default/files/styles/img_search_list_desktop/public/2024-03/2024-03-SCOR_URD_2023_header.jpg?h=82f92a78&itok=vg-oBcmp)
![SCOR-L&H-Expert-View-Vitae-Lymphoma-Report_header](/sites/default/files/styles/img_search_list_desktop/public/2024-03/SCOR-L%26H-Expert-View-Vitae-Lymphoma-Report_header.jpg?h=46fe20cd&itok=quFJkFg2)
![Zeynep Kaya](/sites/default/files/styles/img_search_list_desktop/public/2024-03/Zeynep-Kaya-1000x667.jpg?h=82f92a78&itok=Df82p4V_)
![Dr-Eric-Raymond-1000x667](/sites/default/files/styles/img_search_list_desktop/public/2024-03/Dr-Eric-Raymond-1000x667.jpg?h=82f92a78&itok=Ok8owhlU)
Dr. Eric Raymond is head of Medical Oncology service at Paris Saint-Joseph Hospital and contributes his expertise as a medical advisor to SCOR.
![Antoine-Moll-1000x667](/sites/default/files/styles/img_search_list_desktop/public/2024-03/Antoine-Moll-1000x667.jpg?h=82f92a78&itok=O6KW3zVx)
Antoine has been with SCOR since 2016 in actuarial positions within the Medical & Inclusive Underwriting teams. He was promoted to his current role of Head of Bio Risks Calculators in 2022.
![Joelle Regard](/sites/default/files/styles/img_search_list_desktop/public/2024-03/Joelle-Regard-1000x667.jpg?h=82f92a78&itok=pmzwuo_y)
Joëlle has more than 15 years of medical underwriting experience in the reinsurance industry, mainly in the field of Life & health reinsurance.
![](/sites/default/files/styles/img_search_list_desktop/public/scor_paris3.jpg?h=95651f9d&itok=DjsPrPKA)
![](https://www.scor.com/sites/default/files/styles/img_search_list_desktop/public/2020-09/Russia-Format%20HeaderD8_PagesBase-870x520.jpg?h=a618fb57&itok=mWv-yj1f)
![SCOR_Paris_Kleber_27_©Aude_Monier-Ooshot_1000x667](/sites/default/files/styles/img_search_list_desktop/public/2023-05/SCOR_Paris_Kleber_27_%C2%A9Aude_Monier-Ooshot---BD_1000x667.png?h=82f92a78&itok=oZi3C8Ip)
SCOR dégage un résultat net de EUR 162 millions au quatrième trimestre 2023, contribuant à un résultat net annuel record de EUR 812 millions en 2023, et propose un dividende courant de EUR 1,8 par action
![Richard_Braun_L&H_1000x667](/sites/default/files/styles/img_search_list_desktop/public/2024-02/Richard_Braun_L%26H_1000x667_0.jpg?h=82f92a78&itok=8A7UNcG7)
Frequently presenting medical and underwriting topics and serving in numerous leadership positions for industry organizations, Dr.
![P&C Renewals 2024](/sites/default/files/styles/img_search_list_desktop/public/2024-02/PAndC_Renewals_06022024.jpeg?h=d15dc50e&itok=V5thzLXM)
Croissance des lignes cibles dans des conditions de marché attractives
![Visual Q3 2023](/sites/default/files/styles/img_search_list_desktop/public/2023-11/Visual%20Q3%202023%20Internet.jpg?h=08c6755a&itok=50J5YPZH)